Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Theianova Ltd.

Clinical trials sponsored by Theianova Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New eye drops aim to halt Vision-Threatening keratoconus Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New eye drops aim to halt Vision-Threatening keratoconus

Disease control By invitation only

This early study tests whether TN-001 eye drops are safe and can stop keratoconus, a disease that thins and bulges the cornea, from getting worse. About 20 adults with progressive keratoconus will use the drops twice daily for 3-6 weeks. Researchers will monitor for side effects …

Phase 1/2 • Sponsor: TheiaNova Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:01 UTC